Figure 5.
Analysis of overall survival (OS) of patients with head and neck adenoid cystic carcinoma (HNACC) based on CTA expression status. Patients positive for both pan-Melanoma antigen (pan-MAGE) and New York esophageal squamous cell carcinoma (NY-ESO-1) show significantly worse (p=0.047) OS than patients with negative expression status